ANTARES PHARMA, INC. Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANTARES PHARMA, INC. for June 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 20 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.95 | 565 | 1,667 | 10,285,848 | 10.3 M to 10.3 M (-0.01 %) |
| Jun 13 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.77 | 100,000 | 277,000 | 10,286,413 | 10.4 M to 10.3 M (-0.96 %) |
| Jun 13 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.69 | 100,000 | 269,000 | 10,386,413 | 10.5 M to 10.4 M (-0.95 %) |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Option Exercise | A | 2.70 | 76,548 | 206,680 | 76,548 | |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Option Exercise | A | 2.70 | 76,548 | 206,680 | 76,548 | |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | A | 2.70 | 153,097 | 413,362 | 153,097 | |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 2.70 | 76,548 | 206,680 | 76,548 | |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 2.70 | 76,548 | 206,680 | 76,548 | |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 2.70 | 76,548 | 206,680 | 76,548 | |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Option Exercise | A | 2.70 | 177,453 | 479,123 | 177,453 | |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Grant | A | 2.70 | 91,667 | 247,501 | 289,173 | 197.5 K to 289.2 K (+46.41 %) |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Payment of Exercise | F | 2.70 | 12,923 | 34,892 | 197,506 | 210.4 K to 197.5 K (-6.14 %) |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Option Exercise | A | 2.70 | 177,453 | 479,123 | 177,453 | |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Grant | A | 2.70 | 91,667 | 247,501 | 413,492 | 321.8 K to 413.5 K (+28.48 %) |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Payment of Exercise | F | 2.70 | 9,609 | 25,944 | 321,825 | 331.4 K to 321.8 K (-2.90 %) |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | A | 2.70 | 591,510 | 1,597,077 | 591,510 | |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 2.70 | 305,556 | 825,001 | 1,530,562 | 1.2 M to 1.5 M (+24.94 %) |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.70 | 32,031 | 86,484 | 1,225,006 | 1.3 M to 1.2 M (-2.55 %) |
| Jun 07 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.70 | 20,259 | 54,699 | 10,486,413 | 10.5 M to 10.5 M (-0.19 %) |
| Jun 07 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.70 | 23,129 | 62,448 | 10,506,672 | 10.5 M to 10.5 M (-0.22 %) |
| Jun 05 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.55 | 100,000 | 255,000 | 10,529,801 | 10.6 M to 10.5 M (-0.94 %) |
| Jun 05 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.65 | 100,000 | 265,000 | 10,629,801 | 10.7 M to 10.6 M (-0.93 %) |
| Jun 05 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.70 | 56,612 | 152,852 | 10,729,801 | 10.8 M to 10.7 M (-0.52 %) |
| Jun 05 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.69 | 34,402 | 92,541 | 1,257,037 | 1.3 M to 1.3 M (-2.66 %) |
| Jun 05 2018 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Payment of Exercise | F | 2.69 | 15,422 | 41,485 | 210,429 | 225.9 K to 210.4 K (-6.83 %) |
| Jun 01 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.60 | 78,938 | 205,239 | 10,786,413 | 10.9 M to 10.8 M (-0.73 %) |
| Jun 01 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.55 | 100,000 | 255,000 | 10,865,351 | 11 M to 10.9 M (-0.91 %) |